Mechanisms of connective tissue matrix destruction in periodontitis

Periodontology 2000

Volumn 14, Issue 1, 1997, Pages 144-157

  Reynolds, John J ^a   Meikle, Murray C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; METALLOPROTEINASE; PROTEINASE INHIBITOR; SCLEROPROTEIN;

CONNECTIVE TISSUE; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; PERIODONTITIS; REVIEW;

COLLAGEN; CONNECTIVE TISSUE; CYTOKINES; ENZYME ACTIVATION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; METALLOENDOPEPTIDASES; PERIODONTITIS; PROTEASE INHIBITORS;

EID: 0031152007     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1997.tb00195.x     Document Type: Article

References (99)

1. Alexander MB, Damoulis PD. The role of cytokines in the pathogenesis of periodontal disease. Curr Opin Periodontol 1994: 39-53.
2. 2 stimulates osteoclast formation via endogenous IL-1β expressed through protein kinase A. J Immunol 1996: 156: 1931-1936.
3. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 1996: 93: 14014-14019.
4. Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 1995: 270: 14313-14318.
5. Arner EC, Pratta MA, Freimark B, Lischwe M, Trzaskos JM, Magolda RL, Wright SW. Isothiazolones interfere with normal matrix metalloproteinase activation and inhibit cartilage proteoglycan degradation. Biochem J 1996: 318: 417-424.
6. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, Murphy G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995: 270: 30479-30485.
7. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 1996: 8: 731-738.
8. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990: 348: 699-704.
9. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993: 64: 474-484.
10. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995: 7: 728-735.
11. Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, ed. Matrix metalloproteinases and inhibitors. Stuttgart: Gustav Fischer Verlag, 1992.
12. Breckon JJW, Hembry RM, Reynolds JJ, Meikle MC. Regional and temporal changes in the synthesis of matrix metalloproteinases and TIMP-1 during development of the rabbit mandibular condyle. J Anat 1994: 184: 99-110.
13. Brooks PC, Stromblad S, Sanders LC, Von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996: 85: 683-693.
14. Brown CC, Hembry RM, Reynolds JJ. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg (Am) 1989: 71A: 580-593.
15. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol 1996: 154: 6484-6491.
16. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995: 270: 801-805.
17. Chubinskaya S, Huch K, Mikecz K, CS-Szabo G, Hasty KA, Kuettner KE, Cole AA. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab Invest 1996: 74: 232-240.
18. Cole AA, Chubinskaya S, Schumacher B, Huch K, CS-Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner KE. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996: 271: 11023-11026.
19. Crout RJ, Lee HM, Schroeder K. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol 1996: 67: 506-514.
20. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989: 84: 678-685.
21. DeClerck YA, Imren S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 1994: 30A: 2170-2180.
22. Delaisse J-M, Vaes G. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV, ed. Biology and physiology of the osteoclast. Boca Raton, FL: CRC Press, 1992: 289-314.
23. Delaisse JM, Eeckhout Y, Neff L, François-Gillet C, Henriet P, Su Y, Vaes G, Baron R. (Pro) collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 1993: 106: 1071-1082.
24. Dhawan S, Wahl LM, Heredia A, Zhang YH, Epstein JS, Meltzer MS, Hewlett IK. Interferon-gamma inhibits HIV-induced invasiveness of monocytes. J Leukoc Biol 1995: 58: 713-716.
25. Docherty AJP, O'Connell J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 1992: 10: 200-207.
26. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987: 6: 1899-1904.
27. Everts V, Delaisse J-M, Korper W, Niehof A, Vaes G, Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 1992: 150: 221-231.
28. Everts V, Van der Zee E, Creemers L, Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 1996: 28: 229-245.
29. Fang J, Zhu Y-Y, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996: 93: 5753-5758.
30. Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994: 269: 16766-16773.
31. Hayakawa H, Yamashita K, Ohwaki K, Sawa M, Noguchi T, Iwata K, Hayakawa T. Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjects. J Periodont Res 1994: 29: 305-308.
32. 2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun 1987: 55: 2148-2154.
33. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995: 54: 25-32.
34. Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett 1992: 310: 175-178.
35. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 1994: 56: 118-130.
36. Hill PA, Murphy G, Docherty AJP, Hembry RM, Millican TA, Reynolds JJ, Meikle MC. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 1994: 107: 3055-3064.
37. Hill PA, Docherty AJP, Bottomley KMK, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 1995: 308: 167-175.
38. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995: 129: 867-879.
39. Kapila YL, Kapila S, Johnson PW. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol 1996: 15: 251-261.
40. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996: 271: 17124-17131.
41. Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 1996: 41: 253-262.
42. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer J-M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995: 96: 2304-2310.
43. Larivee J, Sodek J, Ferrier JM. Collagenase and collagenase inhibitor activities in crevicular fluid of patients receiving treatment for localized juvenile periodontitis. J Periodont Res 1986: 21: 702-715.
44. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994: 269: 9352-9360.
45. Lee W, Aitken S, Sodek J, McCulloch CAG. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodont Res 1995: 30: 23-33.
46. Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE, Blow DM. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium linked, fourbladed β-propeller. Structure 1995: 3: 541-549.
47. Lohi J, Lehti K, Westermarck J, Kahari VM, Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristat 13-acetate. Eur J Biochem 1996: 239: 239-247.
48. Makela M, Salo T, Uitto V-J, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994: 73: 1397-1406.
49. Mann EA, Hibbs MS, Spiro JD, Bowik C, Wang XZ, Clawson M, Chen LL. Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumor necrosis factor-alpha. Ann Otol Rhinol Laryngol 1995: 104: 203-209.
50. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K-I, Cloutier J-M, Pelletier J-P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994: 70: 807-815.
51. Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992: 14: 455-463.
52. Meikle MC, Heath JK, Reynolds JJ. Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. J Oral Pathol 1986: 15: 239-250.
53. Meikle MC, McAlpine CG, Heath JK, Newman HN, Reynolds JJ. Interleukin-1 production by peripheral blood mononuclear cells from patients with severe periodontitis. In: Lehner T, Cimasoni G, ed. The borderland between caries and periodontal disease. Geneva: Editions Medecine et Hygiene, 1986: 283-290.
54. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989: 24: 207-213.
55. Meikle MC, McFarland CG, Newman HN, Reynolds JJ. Cytokines and connective tissue degradation in chronic inflammatory periodontal disease. In: Newman HN, Williams DM, ed. Inflammation and immunology in chronic inflammatory periodontal disease. Northwood: Science Reviews, 1992: 87-106.
56. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodont Res 1994: 29: 118-126.
57. Mergenhagen SE. Thymocyte activating factor(s) in human gingival fluids. J Dent Res 1984: 63: 461-464.
58. Murphy G, Reynolds JJ. Extracellular matrix degradation. In: Royce PM, Steinmann B, ed. Connective tissue and its heritable disorders. New York: Wiley-Liss, 1993: 287-316.
59. Murphy GJP, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 1991: 289: 4-7.
60. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci 1992: 667: 1-12.
61. Murphy G, Willenbrock F, Ward R, O'Shea M, Docherty A. Studies on the structure and function of the matrix metalloproteinases and their inhibitors. In: Bond JS, Barrett AJ, ed. Proteolysis and protein turnover. Colchester: Portland Press, 1994: 25-32.
62. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992: 267: 3581-3584.
63. Okada A, Bellocq JP, Rouyer N, Chenard M-P, Rio M-C, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A 1995: 92: 2730-2734.
64. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995: 72: 311-322.
65. Okamatsu Y, Kobayashi M, Nishihara T, Hasegawa K. Interleukin-la produced in human gingival fibroblasts induces several activities related to the progression of periodontitis by direct contact. J Periodont Res 1996: 31: 355-364.
66. O'Shea M, Willenbrock F, Williamson RA, Cockett MI, Freedman RB, Reynolds JJ, Docherty AJP, Murphy G. Sitedirected mutations that alter the inhibitor activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 1992: 31: 10146-10152.
67. Overall CM, Wiebkin OW, Thonard JC. Demonstration of tissue collagenase activity in vivo and its relationship to inflammation severity in human gingiva. J Periodont Res 1987: 22: 81-88.
68. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992: 267: 17321-17326.
69. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995: 375: 244-247.
70. Pinchback JS, Gibbins JR, Hunter N. Vascular co-localization of proteolytic enzymes and proteinase inhibitors in advanced periodontitis. J Pathol 1996: 179: 326-332.
71. Pourtaghi N, Radvar M, Mooney J, Kinane DF. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid. J Periodontol 1996: 67: 866-870.
72. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996: 56: 944-949.
73. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996: 97: 2011-2019.
74. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994: 8: 312-319.
75. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory disfunction in disease. Biol Chem Hoppe-Seyler 1995: 376: 345-355.
76. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996: 3: 85-96.
77. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994: 370: 61-65.
78. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996: 393: 101-104.
79. Shapiro SD, Kobayashi DK, Welgus HG. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J Biol Chem 1992: 267: 13890-13894.
80. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993: 268: 23824-23829.
81. Smith GN, Brandt KD, Hasty KA. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 1996: 39: 235-244.
82. Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, Saari H, Uitto V-J. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992: 60: 4491-4495.
83. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990: 265: 13933-13938.
84. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth F-X, McKay DB, Bode W. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995: 4: 823-840.
85. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995: 270: 5331-5338.
86. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee HM, Uitto V-J, Saari H, Konttinen YT. Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 1992: 36: 227-229.
87. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995: 270: 23013-23020.
88. Teronen O, Salo T, Konttinen YT, Rifkin B, Vernillo A, Ramamurthy NS, Kjeldsen L, Borregaard N, Hietanen J, Sorsa T. Identification and characterization of gelatinases/type IV collagenases in jaw cysts. J Oral Pathol Med 1995: 24: 78-84.
89. Tewari M, Tuncay OC, Milchman A, Reddy PJ, Reddy CD, Cressman DE, Taub R, Newton RC, Tewari DS. Association of interleukin-1-induced, NFκB DNA-binding activity with collagenase gene expression in human gingival fibroblasts. Arch Oral Biol 1996: 41: 461-468.
90. Van der Zee E, Everts V, Beertsen W. Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation. J Periodont Res 1996: 31: 483-488.
91. Villela B, Cogen RB, Bartolucci AA, Birkedal-Hansen H. Collagenolytic activity in crevicular fluid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J Periodont Res 1987: 22: 381-389.
92. Ward RV, Atkinson SJ, Slocombe PM, Docherty AJP, Reynolds JJ, Murphy G. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1991: 1079: 242-246.
93. Ward RV, Atkinson SJ, Reynolds JJ, Murphy G. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem J 1994: 304: 263-269.
94. Westerlund U, Ingman T, Lukinmaa P-L, Salo T, Kjeldsen L, Borregaard N, Tjaderhane L, Konttinen YT, Sorsa T. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996: 75: 1553-1563.
95. West-Mays JA, Strissel KJ, Sadow PM, Fini ME. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1α autocrine loop. Proc Natl Acad Sci U S A 1995: 92: 6768-6772.
96. Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995: 231: 602-608.
97. Williamson RA, Marston FAO, Angal S, Koklitis P, Panico M, Morris HR, Carne AF, Smith BJ, Harris TJR, Freedman RB. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 1990: 268: 267-274.
98. Wilson M, Reddi K, Henderson B. Cytokine-induced components of periodontopathogenic bacteria. J Periodont Res 1996: 31: 393-407.
99. Woolley DE, Davies RM. Immunolocalization of collagenase in periodontal disease. J Periodont Res 1981: 16: 292-297.